Tilbage til menuen

2006

No	Author	Title	Media
1	Aegidius K, Zwart JA, Hagen K, Schei B, Stovner LJ.	Oral contraceptives and increased headache prevalence - The Head-HUNT Study.	Neurology 2006;66:349-353.
2	Ashina S, Zeeberg P, Jensen RH, Ashina M.	Medicinoverforbrugs hovedpine.	Ugeskrift for Læger 2006;168:1015-1019.
3	Ashina S, Bendtsen L, Ashina M, Magerl W, Jensen R.	Generalized hyperalgesia in patients with chronic tension-type headache.	Cephalalgia 2006;26:940-948.
4	Bendtsen L, Jensen R.	Tension-type headache: the most common, but also the most neglected, headache disorder.	Curr Opin Neurol 2006;19:305-309.
5	Birk S, Kruuse C, Petersen KA, Tfelt-Hansen P, Olesen J.	The headache- inducing effect of cilostazol in human volunteers.	Cephalalgia 2006;26:1304-1309.
6	Buchgreitz L, Lyngberg AC, Bendtsen L, Jensen R.	Frequency of headache is related to sensitization: a population study.	Pain 2006;123:19-27.
7	Eriksen MK, Thomsen LL, Olesen J.	Implications of clinical subtypes of migraine with aura.	Headache 2006;46:286-297.
8	Evers S, Olesen J.	Botulinum toxin in headache treatment: the end of the road?	Cephalalgia 2006;26:769-771.
9	Hansen JM, Sitarz J, Birk S, Rahmann AM, Oturai PS, Fahrenkrug J, Olesen J, Ashina M.	Vasoactive intestinal polypeptide evokes only a minimal headache in healthy volunteers.	Cephalalgia 2006;26:992-1003.
10	Hillerup S, Jensen R.	Nerve injury caused by mandibular block analgesia.	Int J Oral Maxillofac Surg 2006;35:437-443.
11	Jensen R, Bendtsen L.	Tension-type headache: why does this condition have to fight for its recognition?	Current pain and headache reports 2006;10:454-458.
12	Jensen RH, Kruuse C, Bendtsen L.	Hovedpineklassifikation, ny udgave.	Ugeskrift for læger 2006;168:1019-1023.
13	Jensen RH.	Hovedpine.	Ugeskrift for læger 2006;168:1950-1953.
14	Juhl L, Petersen KA, Larsen EH, Jansen-Olesen I, Olesen J.	The in vivo effect of adrenomedullin on rat dural and pial arteries.	Eur J Pharmacol 2006;538:101-7.
15	Juhl L, Petersen KA, Larsen EH, Jansen-Olesen I, Olesen J.	The in vivo effect of adrenomedullin on rat dural and pial arteries.	Eur J Pharmacol 2006;538:101-107.
16	Kirchmann M.	Migraine with aura: new understanding from clinical epidemiologic studies.	Curr Opin Neurol 2006;19:286-293.
17	Kirchmann M, Thomsen LL, Olesen J.	Basilar-type migraine: clinical, epidemiologic, and genetic features.	Neurology 2006;66:880-886.
18	Kirchmann M, Seven E, Bjornsson A, Bjornssdottir G, Gulcher JR,Stefansson K, Olesen J.	Validation of the deCODE Migraine Questionnaire (DMQ3) for use in genetic studies.	European journal of neurology 2006;13:1239-1244.
19	Kirchmann M, Thomsen LL, Olesen J.	The CACNA1A and ATP1A2 genes are not involved in dominantly inherited migraine with aura.	Neuropsychiatric genetics 2006;141:250-256.
20	Kruse LS, Sandholdt NT, Gammeltoft S, Olesen J, Kruuse C.	Phosphodiesterase 3 and 5 and cyclic nucleotide-gated ion channel expression in rat trigeminovascular system.	Neurosci Lett 2006;404:202-207.
21	Kruuse C, Lassen LH, Iversen HK, Oestergaard S, Olesen J.	Dipyridamole may induce migraine in patients with migraine without aura.	Cephalalgia 2006;26:925-933.
22	Lampl C, Marecek S, May A, Bendtsen L.	A prospective, open-label, long- term study of the efficacy and tolerability of topiramate in the prophylaxis of chronic tension-type headache.	Cephalalgia 2006;26:1203- 1208.
23	23. Nappi G, Jensen R, Nappi RE, Sances G, Torelli P, Olesen J.	Diaries and calendars for migraine. A review.	Cephalalgia 2006;26:905-916.
24	Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, Gobel H, Lainez MJ, Lance JW, Lipton RB, Nappi G, Sakai F, Schoenen J, Silberstein SD, Steiner TJ.	New appendix criteria open for a broader concept of chronic migraine.	Cephalalgia 2006;26:742-746.
25	Olesen J.	Are headache disorders caused by neurobiological mechanisms?	Curr Opin Neurol 2006;19:277-280.
26	Olesen J, Freund TF.	European Brain Council: partnership to promote European and national brain research.	Trends Neurosci 2006;29:493-495.
27	Olesen J.	International Classification of Headache Disorders, Second Edition (ICHD-2): current status and future revisions.	Cephalalgia 2006;26:1409-1410.
28	Olesen J.	Migraine and probable migraine-results of FRAMIG 3, a French nationwide survey carried out according to the 2004 IHS classification.	Cephalalgia 2006;26:1347.
29	Olesen J, Baker MG, Freund T, di Luca M, Mendlewicz J, Ragan I, Westphal M.	Consensus document on European brain research.	J Neurol Neurosurg Psychiatry 2006;77 Suppl 1:1-49.
30	Olesen J, Baker MG, Freund T, di LM, Mendlewicz J, Ragan I, Westphal M.	Consensus document on European brain research.	Journal of neurology, neurosurgery, and psychiatry 2006;77 Suppl 1:i1-49.
31	Ploug KB, Edvinsson L, Olesen J, Jansen-Olesen I.	Pharmacological and molecular comparison of K(ATP) channels in rat basilar and middle cerebral arteries.	Eur J Pharmacol 2006;553:254-262.
32	Ramadan NM, Olesen J.	Classification of headache disorders.	Semin Neurol 2006;26:157-162.
33	Saper J, Dahlof C, So Y, Tfelt-Hansen P, Malbecq W, Loeys T, Barraclough E, Klipfel M, Lines C, Visser H, Reines S, Yuen E.	Rofecoxib in the acute treatment of migraine: A randomized controlled clinical trial.	Headache 2006;46:264-275.
34	Silberstein SD, Gobel H, Jensen R, Elkind AH, Degryse R, Walcott JM, Turkel C.	Botulinum toxin type A in the prophylactic treatment of chronic tension-type headache: a multicentre, double-blind, randomized, placebo-controlled, parallel-group study.	Cephalalgia 2006;26:790-800.
35	Skau M, Brennum J, Gjerris F, Jensen R.	What is new about idiopathic intracranial hypertension? An updated review of mechanism and treatment.	Cephalalgia 2006;26:384-399.
36	Sobocki P, Lekander I, Berwick S, Olesen J, Jonsson B.	Resource allocation to brain research in Europe (RABRE).	Eur J Neurosci 2006;24:2691-2693.
37	Tfelt-Hansen P, Olesen J.	Increasing the effect of triptans in migraine.	Lancet 2006;368:1313-1314.
38	Tfelt-Hansen P, Jensen RH.	Klyngehovedpine (Hortons hovedpine).	Ugeskrift for Læger 2006;168:4417-4422.
39	Tfelt-Hansen P.	A review of evidence-based medicine and meta-analytic reviews in migraine.	Cephalalgia 2006;26:1265-1274.
40	Tfelt-Hansen P, Bach FW, Daugaard D, Tsiropoulos I, Riddersholm B.	Treatment with sumatriptan 50 mg in the mild phase of migraine attacks in patients with infrequent attacks: a randomised, double-blind, placebo-controlled study.	The journal of headache and pain 2006;7:389-394.
41	Tfelt-Hansen P, Iversen HK.	Triptaner i migraenebehandlingen. En oversigt baseret pa tre Cochrane-reviews.	Ugeskrift for læger 2006;168:1850-1853.
42	Tfelt-Hansen P.	Understanding clinical trials in migraine.	The journal of headache and pain 2006;7:101-108.
43	Tfelt-Hansen P.	The fixed combination of acetylsalicylic acid, paracetamol and caffeine.	Cephalalgia 2006;26:1487.
44	Zeeberg P, Olesen J, Jensen R.	Probable medication-overuse headache: the effect of a 2-month drug-free period.	Neurology 2006;66:1894-1898.
45	Zeeberg P, Olesen J, Jensen R.	Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness.	Cephalalgia 2006;26:1192-1198.

Redaktør

Regionhovedstaden
E-mail:

DHC

Danish Headache Center

Contact:

Danish Headache Center
DHC Glostrup Hospital Nord
Building 14
Ndr. Ringvej 69
DK-2600 Glostrup
Denmark

Phone: +45 38 63 20 62
Fax: +45 43 23 38 39

Location of Danish Headache Center - MAP